Verrica Pharmaceuticals (VRCA) Shares Outstanding (2017 - 2026)
Verrica Pharmaceuticals (VRCA) recorded Shares Outstanding of 21.31 million in Q2 2026, up 124.5% from 9.49 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Verrica Pharmaceuticals (VRCA) Shares Outstanding (2017 - 2026) Analysis & Trends
For FY2025, Verrica Pharmaceuticals reported Shares Outstanding of 10.65 million, up 105.6% from FY2024.
- Annual Shares Outstanding has increased for eight straight years, with a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding came in at 5.18 million in FY2024 (+14.3%), 4.53 million in FY2023 (+32.7%), 3.42 million in FY2022 (+26.3%) and 2.7 million in FY2021 (+8.2%).
- On a year-over-year basis, Shares Outstanding has increased for 16 consecutive quarters, with growth averaging 85.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding ran from 0.0% in Q2 2022 to 124.6% in Q1 2026.
- Per Business Quant, the preceding three quarters came in at 21.31 million (Q1 2026), 10.65 million (Q4 2025) and 9.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 891.90 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.94 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 1.55 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 541.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Verrica Pharmaceuticals | 62.02 Mn | -21.03 Mn | - | 21.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.31 Mn |
| Mar 31, 2026 | 21.31 Mn |
| Dec 31, 2025 | 10.65 Mn |
| Sep 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.65 Mn |
| Mar 31, 2024 | 4.65 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 4.61 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Mar 31, 2023 | 4.30 Mn |
| Dec 31, 2022 | 3.42 Mn |
| Sep 30, 2022 | 4.03 Mn |
| Jun 30, 2022 | 2.75 Mn |
| Mar 31, 2022 | 2.75 Mn |
| Dec 31, 2021 | 2.70 Mn |
| Sep 30, 2021 | 2.75 Mn |
API Access
Verrica Pharmaceuticals Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=VRCA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();